Stock Earnings

Question 1

Mirum Pharmaceuticals Incの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Mirum Pharmaceuticals Incの総資産は$670で、純lossは$-87です。

Question 2

MIRMの主要な財務比率は何ですか？

Accepted Answer

Mirum Pharmaceuticals Incの流動比率は1.5、純利益率は-25.89、1株当たり売上高は$7.07です。

Question 3

Mirum Pharmaceuticals Incの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Mirum Pharmaceuticals Inc largest revenue segment is Pharmaceutical, at a revenue of 336,409,000 in the most earnings release.For geography, United States is the primary market for Mirum Pharmaceuticals Inc, at a revenue of 274,173,000.

Question 4

Mirum Pharmaceuticals Incは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、Mirum Pharmaceuticals Incの純lossは$-87です。

Question 5

Mirum Pharmaceuticals Incに負債はありますか？

Accepted Answer

yes、Mirum Pharmaceuticals Incの負債は445です。

Question 6

Mirum Pharmaceuticals Incの発行済株式数は何株ですか？

Accepted Answer

Mirum Pharmaceuticals Incの総発行済株式数は48.33株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	429	336	186	77	19	0
Revenue Growth (YoY)	63%	81%	142%	305%	--	--
Cost of Revenue	90	81	47	12	1	--
Gross Profit	339	255	139	64	17	--
Selling, General & Admin	228	202	145	89	59	22
Research & Development	167	140	102	106	131	81
Operating Expenses	396	342	248	195	190	104
Other Non Operating Income (Expenses)	1	1	-2	0	0	0
Pretax Income	-57	-86	-162	-142	-83	-103
Income Tax Expense	1	1	0	-6	0	0
Net Income	-58	-87	-163	-135	-83	-103
Net Income Growth	-47%	-47%	21%	63%	-19%	98%
Shares Outstanding (Diluted)	49.72	47.52	40.88	33.84	30.32	25.25
Shares Change (YoY)	5%	16%	21%	12%	20%	10%
EPS (Diluted)	-1.17	-1.85	-3.99	-4.01	-2.77	-4.09
EPS Growth	-49%	-54%	0%	45%	-32%	79%
Free Cash Flow	-1	-10	-91	-120	-151	-89
Free Cash Flow Per Share	-0.02	-0.21	-2.22	-3.54	-4.98	-3.52
Gross Margin	79.02%	75.89%	74.73%	83.11%	89.47%	--
Operating Margin	-13.28%	-25.89%	-58.6%	-170.12%	-910.52%	0%
Profit Margin	-13.51%	-25.89%	-87.63%	-175.32%	-436.84%	0%
Free Cash Flow Margin	-0.23%	-2.97%	-48.92%	-155.84%	-794.73%	0%
EBITDA	-33	-64	-99	-128	-173	-104
EBITDA Margin	-7.69%	-19.04%	-53.22%	-166.23%	-910.52%	0%
D&A For EBITDA	24	23	10	3	0	0
EBIT	-57	-87	-109	-131	-173	-104
EBIT Margin	-13.28%	-25.89%	-58.6%	-170.12%	-910.52%	0%
Effective Tax Rate	-1.75%	-1.16%	0%	4.22%	0%	0%

Mirum Pharmaceuticals Inc (MIRM) Price

MIRM Stock Price Chart

MIRM Income

Follow-Up Questions